Print-Friendly PDF Print this page

William Neeley is an associate in the firm’s Business Law Department and a member of its Technology Companies & Life Sciences Group. He joined Goodwin Procter in 2011.

Dr. Neeley assists the firm in patent prosecution and in freedom to operate, due diligence, patentability, and invalidity opinion investigations. He has extensive experience in the fields of pharmaceuticals, biotechnology, controlled drug release, organic chemistry, biochemistry, biomaterials and biomedical engineering.

Dr. Neeley was awarded a National Institutes of Health Postdoctoral Fellowship, a Massachusetts Institute of Technology Presidential Graduate Fellowship and a Howard Hughes Medical Institute Undergraduate Research Fellowship. He authored the Most-Cited Article of 2006 in the journal Chemical Research in Toxicology. As an undergraduate, Dr. Neeley received the John C. Sowden Prize in Chemistry for the outstanding graduating senior.

Prior to joining Goodwin Procter, Dr. Neeley was a Technology Specialist in the Chemical & Materials Technologies, Biotechnology, and Pharmaceutical Practice Groups at Wolf, Greenfield & Sacks, P.C.

Prior to his legal career, Dr. Neeley was a Postdoctoral Fellow in the laboratory of Professor Robert Langer at MIT. His research focused primarily on retinal tissue engineering using stem cells and microfabricated polymeric materials.

His doctoral research utilized a combination of synthetic organic chemistry and molecular biology to investigate the molecular mechanisms of carcinogenesis.


Dr. Neeley is an author of numerous peer-reviewed articles in Tissue Engineering, Stem Cells, Biomaterials, Biochemistry, Journal of Biological Chemistry, Organic Letters and Chemical Research in Toxicology. He has also presented his research at national and international conferences.